Simplex Trading’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $148K | Buy |
13,561
+7,260
| +115% | +$90.7K | ﹤0.01% | 4649 |
|
|
2025
Q4 | $81.5K | Sell |
6,301
-1,514
| -19% | -$19.4K | ﹤0.01% | 5198 |
|
|
2025
Q3 | $100K | Buy |
+7,815
| New | +$104K | ﹤0.01% | 5751 |
|
|
2025
Q1 | – | Sell |
-3,587
| Closed | -$81.5K | – | 9284 |
|
|
2024
Q4 | $106K | Buy |
+3,587
| New | +$75.9K | ﹤0.01% | 5123 |
|
|
2024
Q2 | – | Sell |
-28,986
| Closed | -$510K | – | 9503 |
|
|
2024
Q1 | $453K | Sell |
28,986
-27,125
| -48% | -$399K | ﹤0.01% | 3955 |
|
|
2023
Q4 | $837K | Buy |
+56,111
| New | +$751K | ﹤0.01% | 3178 |
|
|
2023
Q3 | – | Sell |
-11,174
| Closed | -$322K | – | 9471 |
|
|
2023
Q2 | $463K | Buy |
11,174
+11,074
| +11,074% | +$688K | ﹤0.01% | 3388 |
|
|
2023
Q1 | $6K | Sell |
100
-298
| -75% | -$23.8K | ﹤0.01% | 7918 |
|
|
2022
Q4 | $29K | Buy |
398
+200
| +101% | +$15K | ﹤0.01% | 6512 |
|
|
2022
Q3 | $15K | Sell |
198
-1,370
| -87% | -$107K | ﹤0.01% | 7835 |
|
|
2022
Q2 | $108K | Sell |
1,568
-6,137
| -80% | -$462K | ﹤0.01% | 5476 |
|
|
2022
Q1 | $638K | Sell |
7,705
-3,102
| -29% | -$229K | ﹤0.01% | 3517 |
|
|
2021
Q4 | $811K | Buy |
10,807
+1,475
| +16% | +$148K | ﹤0.01% | 3149 |
|
|
2021
Q3 | $1.77M | Sell |
9,332
-1,416
| -13% | -$214K | ﹤0.01% | 2312 |
|
|
2021
Q2 | $2.38M | Buy |
10,748
+2,488
| +30% | +$484K | ﹤0.01% | 1942 |
|
|
2021
Q1 | $1.09M | Buy |
8,260
+7,994
| +3,005% | +$1.26M | ﹤0.01% | 2292 |
|
|
2020
Q4 | $46K | Hold |
266
| – | – | ﹤0.01% | 6281 |
|
|
2020
Q3 | $29K | Sell |
266
-9,525
| -97% | -$762K | ﹤0.01% | 6105 |
|
|
2020
Q2 | $580K | Buy |
9,791
+9,591
| +4,796% | +$631K | ﹤0.01% | 2731 |
|
|
2020
Q1 | $13K | Buy |
+200
| New | +$15.8K | ﹤0.01% | 6294 |
|
|
2019
Q4 | – | Sell |
-14,177
| Closed | -$1.14M | – | 7756 |
|
|
2019
Q3 | $1.06M | Sell |
14,177
-4,090
| -22% | -$327K | ﹤0.01% | 1888 |
|
|
2019
Q2 | $1.16M | Buy |
+18,267
| New | +$926K | ﹤0.01% | 1776 |
|
|
2019
Q1 | – | Sell |
-7,243
| Closed | -$349K | – | 7626 |
|
|
2018
Q4 | $242K | Sell |
7,243
-599
| -8% | -$21.9K | ﹤0.01% | 2945 |
|
|
2018
Q3 | $410K | Buy |
7,842
+7,409
| +1,711% | +$295K | ﹤0.01% | 2836 |
|
|
2018
Q2 | $13K | Buy |
+433
| New | +$12K | ﹤0.01% | 6175 |
|
|
2018
Q1 | – | Sell |
-6,132
| Closed | -$132K | – | 6636 |
|
|
2017
Q4 | $123K | Buy |
6,132
+3,533
| +136% | +$68K | 0.01% | 1641 |
|
|
2017
Q3 | $51K | Sell |
2,599
-3,733
| -59% | -$73.4K | ﹤0.01% | 2285 |
|
|
2017
Q2 | $109K | Buy |
+6,332
| New | +$81.7K | ﹤0.01% | 1683 |
|
|
2017
Q1 | – | Sell |
-28,190
| Closed | -$204K | – | 6588 |
|
|
2016
Q4 | $221K | Buy |
+28,190
| New | +$227K | 0.01% | 985 |
|
|
2016
Q3 | – | Sell |
-3,023
| Closed | -$27.6K | – | 6252 |
|
|
2016
Q2 | $35K | Buy |
+3,023
| New | +$37.8K | ﹤0.01% | 2393 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM
Simplex Trading's NVCR Position: Q1 2026 in Review
Simplex Trading increased its NovoCure (NVCR) stake by 115% in Q1 2026, buying an estimated $90.7K and bringing the position to 13,561 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4649.
Simplex Trading first reported a position in NVCR in Q2 2016 and has held it in 30 quarters since. The position peaked at $2.38M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.
- Simplex Trading held 13,561 shares of NovoCure worth $148K as of Q1 2026.
- Simplex Trading bought 7,260 NovoCure shares in Q1 2026, an estimated $90.7K.
- NovoCure made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4649 holding.
- Simplex Trading first reported a position in NovoCure in Q2 2016 and has held it in 30 quarters since.
- Simplex Trading's NovoCure position peaked at $2.38M in Q2 2021.
- 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.